*ST苏吴（600200）5月28日主力资金净流入2185.70万元

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of *ST Suwu, indicating a significant decline in revenue and net profit for the first quarter of 2025 compared to the previous year [1] - As of May 28, 2025, *ST Suwu's stock price closed at 2.8 yuan, reflecting a 4.87% increase with a trading volume of 594,000 hands and a transaction amount of 164 million yuan [1] - The company experienced a net inflow of main funds amounting to 21.86 million yuan, accounting for 13.29% of the total transaction amount, with large orders contributing significantly to this inflow [1] Group 2 - For the first quarter of 2025, *ST Suwu reported total operating revenue of 317 million yuan, a year-on-year decrease of 25.44%, and a net profit attributable to shareholders of 70.32 million yuan, down 1489.93% year-on-year [1] - The company's liquidity ratios are reported as a current ratio of 1.477 and a quick ratio of 1.426, with a debt-to-asset ratio of 54.16% [1] - Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. has made investments in 13 enterprises and has participated in 5 bidding projects, along with holding 47 trademark registrations and 2 patents [2]